ArticleJournal of obstetrics and gynaecology of India2025
Intrauterine Transfusion for Fetal Anemia: An 8-Year Experience from a Tertiary Care Center.
Article in Journal of obstetrics and gynaecology of India, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Timed and targeted transfusion in Rh isoimmunization: A case report on early detection and neonatal outcomes.Qatar medical journal · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Aim and Background: To study the procedure-related complications and outcomes of intrauterine transfusion (IUT) in fetal anemia. Methods: A single tertiary care center, retrospective observational study of severe fetal anemia treated with IUT. The influence of gestational age (GA) at transfusion, hydrops, and route of transfusion on procedure-related complications were studied and the postnatal outcomes were recorded. Results: A total of 59 IUT's were performed in 33 anemic fetuses. Rh isoimmunization (30/33) was the most common indication in 90.9%. The mean GA of fetuses who developed procedural complications was 3 weeks earlier (Mean: 26 weeks) than in those in whom the procedure was uneventful (Mean: 29.8 weeks). The umbilical vein (UV) was the main route of entry in 86.4% of fetuses. All hydropic fetuses in the study needed an earlier transfusion than the nonhydropic ones. A total of six procedural complications were observed which varied from mild bradycardia ( Conclusion: Early GA of transfusion and the presence of hydrops increased procedure-related adverse events. Small sample size and confounding factors like hydrops and early gestational age at transfusions made it difficult to comment on the influence of route on procedure-related complications.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.